Mohamed Hammami Selected Research

2,4-Dichlorophenoxyacetic Acid (2,4 Dichlorophenoxyacetic Acid)

7/2013	Alteration of lipid status and lipid metabolism, induction of oxidative stress and lipid peroxidation by 2,4-dichlorophenoxyacetic herbicide in rat liver.
11/2012	Biochemical and histological evaluation of kidney damage after sub-acute exposure to 2,4-dichlorophenoxyacetic herbicide in rats: involvement of oxidative stress.
1/2012	Hypolipidimic and antioxidant activities of virgin olive oil and its fractions in 2,4-diclorophenoxyacetic acid-treated rats.
8/2010	Hepatotoxicity induced by sub-acute exposure of rats to 2,4-Dichlorophenoxyacetic acid based herbicide "Désormone lourd".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohamed Hammami Research Topics

Disease

14	Coronary Artery Disease (Coronary Atherosclerosis) 03/2018 - 01/2005
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 08/2010
8	Body Weight (Weight, Body) 01/2018 - 08/2010
7	Inflammation (Inflammations) 11/2021 - 02/2007
7	Obesity 04/2020 - 09/2011
7	Atherosclerosis 08/2017 - 01/2006
7	Type 2 Diabetes Mellitus (MODY) 05/2013 - 01/2005
6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2012
4	Mitochondrial Diseases (Mitochondrial Disease) 10/2017 - 01/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2012
3	Neoplasms (Cancer) 01/2021 - 08/2010
3	Dyslipidemias (Dyslipidemia) 04/2020 - 04/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 09/2011
3	Insulin Resistance 01/2018 - 09/2011
3	Necrosis 01/2016 - 02/2007
3	Myocardial Infarction 12/2011 - 02/2010
2	Rheumatoid Arthritis 07/2018 - 01/2018
2	Non-alcoholic Fatty Liver Disease 01/2016 - 09/2011
2	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2013 - 11/2012
2	Renal Insufficiency (Renal Failure) 11/2012 - 03/2012
1	Infections 02/2022
1	Sarcopenia 11/2021
1	COVID-19 01/2021
1	Neuroblastoma 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Macular Degeneration (Age-Related Maculopathy) 01/2021
1	Frailty 01/2020
1	Rupture 01/2020
1	Overweight 01/2020
1	Dehydration (Water Stress) 08/2019
1	Celiac Disease (Celiac Sprue) 01/2018
1	Cardiogenic Shock 01/2018
1	Refeeding Syndrome 01/2018
1	Diarrhea 01/2018
1	Psychomotor Agitation (Akathisia) 01/2018
1	Prodromal Symptoms 01/2018
1	Erectile Dysfunction 12/2017
1	Hepatocellular Carcinoma (Hepatoma) 12/2017
1	Peroxisomal Disorders (Peroxisomal Disorder) 01/2017

Drug/Important Bio-Agent (IBA)

14	LipidsIBA 01/2021 - 01/2005
10	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 09/2008
9	CholesterolIBA 04/2020 - 10/2007
7	OxysterolsIBA 11/2021 - 11/2014
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2020 - 02/2010
5	7-ketocholesterolIBA 01/2021 - 07/2015
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2012
5	pentosidineIBA 07/2018 - 11/2012
4	OilsIBA 11/2021 - 09/2011
4	AngiotensinogenIBA 04/2020 - 07/2010
4	Advanced Glycation End ProductsIBA 07/2018 - 11/2012
4	2,4-Dichlorophenoxyacetic Acid (2,4 Dichlorophenoxyacetic Acid)IBA 07/2013 - 08/2010
4	HomocysteineIBA 10/2010 - 09/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 08/2010
3	CytokinesIBA 01/2020 - 01/2016
3	Trans Fatty AcidsIBA 03/2018 - 09/2011
3	sodium arsenateIBA 12/2017 - 02/2014
3	arsenic acid (arsenate)IBA 12/2017 - 02/2014
3	AntioxidantsIBA 06/2017 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2016
2	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 07/2018 - 01/2016
2	Insulin (Novolin)FDA Link 01/2018 - 01/2016
2	Rosiglitazone (Avandia)FDA Link 01/2018 - 01/2016
2	Receptor for Advanced Glycation End ProductsIBA 01/2018 - 01/2016
2	Lipoproteins (Lipoprotein)IBA 07/2013 - 10/2011
2	AzoxymethaneIBA 12/2012 - 03/2011
2	Triglycerides (Triacylglycerol)IBA 04/2012 - 01/2005
2	CreatinineIBA 03/2012 - 09/2008
2	oxidized low density lipoproteinIBA 07/2011 - 09/2008
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2010 - 02/2010
2	Cholesterol Ester Transfer ProteinsIBA 09/2010 - 03/2004
2	Peptides (Polypeptides)IBA 09/2010 - 06/2009
2	Phospholipid Transfer ProteinsIBA 06/2009 - 10/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2022
1	milk-thistle extractIBA 01/2021
1	CoagulantsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Arachidonic Acid (Vitamin F)IBA 01/2020
1	apigetrinIBA 08/2019
1	luteolin-7-glucosideIBA 08/2019
1	FlavonoidsIBA 08/2019
1	scolymosideIBA 08/2019
1	GlucosidesIBA 08/2019
1	egg-oilIBA 10/2018
1	ElectrolytesIBA 01/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018
1	Methanol (Carbinol)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Liver GlycogenIBA 01/2018
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 10/2017
1	FructoseIBA 06/2017
1	Cholinesterases (Cholinesterase)IBA 06/2017
1	C-Reactive ProteinIBA 01/2017
1	PlasmalogensIBA 01/2017

Therapy/Procedure

3	Mediterranean Diet 11/2021 - 08/2017
3	Therapeutics 01/2021 - 11/2011
1	Nutritional Support (Artificial Feeding) 01/2018
1	Gluten-Free Diet 01/2018